Schedule 13D ownership disclosure

SENESCO TECHNOLOGIES INC

Security class unavailable · CUSIP: 817208507

Event date: 2014-06-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,400,970
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-14-038605
Form type
SC 13D/A
Filer
Eloxx Pharmaceuticals, Inc.
CIK
CIK 1035354
Filed
Jun 19, 2014
Reporting period
Jun 13, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub